Nice — I pulled recent market reports, industry press and company/analyst write-ups and put together a compact, source-backed briefing for the Pharmaceutical Packaging market with a vendor reference list (where public values exist) and the analysis sections you requested.

This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Pharmaceutical Packaging market.

This holistic report presented by the report is also determined to cater to all the market specific information and a take on business analysis and key growth steering best industry practices that optimize million-dollar opportunities amidst staggering competition in Pharmaceutical Packaging market.

Read complete report at: https://www.thebrainyinsights.com/report/pharmaceutical-packaging-market-12579

I focused the answer on (A) market snapshot, (B) vendor references (companies + public values / deal figures where available), and (C) the requested market analysis (Recent developments, Drivers, Restraints, Regional segmentation, Emerging trends, Top use cases, Major challenges, Attractive opportunities, and Key expansion factors). I included source citations for the most important claims.

Quick market snapshot
Multiple market reports show the pharmaceutical-packaging market in the USD ~130–155 billion range for the mid-2020s with forecast CAGRs that vary by publisher (~6–15% depending on forecast horizon and scope). Use these as conservative vs. aggressive bookends.

Subsegments driving value: primary packaging (vials, bottles, blister, prefilled syringes), secondary packaging (cartons, labels), and services (serialization/traceability). Grand View and MarketsandMarkets list plastics/polymers, glass, and advanced drug-delivery systems as high-value categories.

B — Reference of companies (vendors) — with public values / deal notes
Note: many packaging companies report corporate revenues (all industries) rather than an isolated “pharmaceutical packaging” revenue line. Where vendors don’t publish a discrete pharma revenue number I note that and cite a source listing them as a major pharma-packaging player.

Amcor plc — global packaging giant; major deal: announced acquisition of Berry Global (all-stock, ~$8.4B deal) to create a packaging powerhouse (combined company cited with roughly $24B annual revenue pro-forma in press coverage). This creates a very large player across pharma/healthcare packaging categories (closures, tubes, cartons, flexible packaging).

Berry Global — (being acquired by Amcor); major supplier of rigid & flexible polymer containers, closures and specialty healthcare packaging. Deal value cited above.

Smurfit Kappa / WestRock (combination) — major corrugated & secondary packaging player; combined entity (Smurfit-WestRock) reported as a very large global packaging group after the planned combination (large consumer/healthcare envelope). See press on Smurfit Kappa & WestRock combination.

Gerresheimer AG — leading supplier of glass vials, cartridges and specialty pharma packaging; repeatedly listed among top pharma packaging suppliers in market reports. (Company discloses pharma glass and primary packaging performance in investor materials — not always a standalone corporate pharma revenue line in market reports).

Schott AG — major glass tubular vials and pharma glass supplier (sterile glass packaging for injectables). Frequently cited as a top player.

West Pharmaceutical Services, Inc. — leader in components for injectable drug delivery (stoppers, seals, containers, delivery systems). Listed among top vendors.

AptarGroup, Inc. — specialist in delivery systems, metering pumps, nasal/MDI actuators — frequently listed among leaders.

SGD Pharma, Owens-Illinois (O-I), SGD / SGD Pharma, Becton Dickinson (BD), CCL Industries, Nelipak, Vetter Pharma, PCI Pharma Services — commonly appear in vendor lists and market reports as major players across primary/secondary/sterile packaging and contract packaging services.

If you want an exact table (CSV/Excel) listing ~15 packaging vendors + the precise public metric I used (deal value, corporate revenue, or explicit pharma packaging revenue where published) I can compile that next and include the direct source links for each cell.

C — Market analysis
Recent developments (2023–mid-2025)
Consolidation: large M&A and consolidation moves reshaped the supplier landscape (Amcor → Berry deal; Smurfit Kappa / WestRock combination) — these deals materially change market concentration and supplier scale for pharma packaging.

Regulatory & traceability investments: increasing spend on serialization, aggregation and anti-counterfeiting (serialization services market growing quickly).

Growing demand from biologics & injectables: higher use of glass vials, prefilled syringes, and specialized polymer systems as biologics and injectable therapies expand. Market reports single out biologics as a key growth vector.

Drivers
Biologics & sterile injectable growth → more high-barrier primary packaging (glass, cyclic olefin polymers, prefilled devices).

Stringent regulation & serialization (traceability requirements in many markets) → higher spend for packaging with authentication features.

Rising pharmaceutical volumes globally and expansion of contract-manufacturing/contract-packaging services (CMOs/contract packers).

Raw-material price volatility (polymers, resin, glass) that squeezes margins.

Supply-chain & capacity constraints for highly specialized packaging (e.g., sterile filling lines, siliconized stoppers).

High regulatory compliance cost for sterile and serialization-enabled packaging.

Regional segmentation analysis (high-level)
North America: major share and heavy adoption of advanced delivery systems, serialization and contract packaging; significant capex into pharma packaging lines.

Europe: large glass-vial and specialty packaging manufacturing base (Schott, Gerresheimer) and strict regulatory environment pushing traceability.

Asia-Pacific: fastest growth in consumption and manufacturing (increasing biologics & generic drug manufacturing); many global suppliers expanding capacity here.

Emerging trends
Sustainability & circularity — lightweighting, recyclable materials, mono-material formats; sustainability R&D incorporated in large deals (Amcor announced sustainability investments tied to its Berry deal).

Smart packaging & serialization — integration of RFID, QR codes and digital traceability for anti-counterfeiting + patient engagement.

Prefilled syringes, cartridges & on-body/injectable device growth driven by self-administration trends.

Top use cases
Sterile injectables and biologics (vials, prefilled syringes, stoppers).

Oral solids (blister packs, bottles) for high-volume medicines.

Cold-chain packaging for temperature-sensitive biologics / vaccines.

Major challenges
Meeting sterility & regulatory requirements while controlling costs.

Counterfeit/traceability pressure requiring investment in serialization & aggregation systems.

Integration of sustainability without sacrificing barrier/performance for sensitive drugs.

Attractive opportunities
Contract packer / end-to-end serialization services — service providers that offer fill-finish + serialization + cold chain are in demand.

Sustainable materials & mono-material blister/strip solutions for brand owners seeking circularity.

Specialized packaging for biologics and cell/gene therapies (custom vials, micro-dosing devices).

Key factors of market expansion
Continued growth of biologics & injectable therapeutics.

Regulatory traceability mandates (serialization aggregation) increasing spend on packaging & labeling systems.

Consolidation among large packaging players creating scale to invest in advanced manufacturing and sustainability.

Sources (select, most load-bearing)
Grand View Research — Pharmaceutical Packaging Market (market size, segmentation).

MarketsandMarkets — Pharmaceutical Packaging Market (vendor lists & sizing).

Reuters / Investopedia — Amcor acquisition of Berry Global (deal value & combined revenue).

AP / news on Smurfit Kappa & WestRock combination (industry consolidation).

Grand View / specialized reports on serialization & traceability growth.

If you’d like any of these as a follow-up deliverable, pick one and I’ll build it now:

Vendor table (CSV/Excel) — ~15 vendors, the exact public metric I could find (deal value, corporate revenue, or explicit pharma packaging revenue where published) and a direct source link per cell.

1-page slide (PowerPoint) — market snapshot + top vendors + 3 strategic takeaways.

Deep dive on a subsegment — e.g., sterile injectables packaging (glass vials, prefilled syringes, components, regulatory requirements) or serialization & traceability (market sizing and vendor landscape).

Which one do you want me to assemble now?